MARK4 anticorps (C-Term)

N° du produit ABIN374191

Cet anticorps Chèvre Polyclonal détecte spécifiquement MARK4 dans WB. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour MARK4 anticorps (C-Term) (ABIN374191)

Antigène: MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp MARK4 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-MARK4 anticorps

Épitope: C-Term

Séquence: IKRKPPPGCS DSPGV

Specificité: This antibody detects MARK4 at C-term.

Purification: Ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide

Immunogène: Peptide from the C Terminus of the protein sequence according to NP_113605.2. Genename: MARK4

Information d'application

Indications d'application: Peptide ELISA: Limit dilution 1: 128000. Western blot: 0.3-1 μg/mL. Approx 70 kDa band observed in human prostate lysates(calculated MW of 75.0 kDa according to NP_113605.2).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 0.5 mg/mL

Buffer: Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2 - 8 °C for up to one month or (in aliquots) at -20 °C.

Détails sur MARK4

Antigène: MARK4 (MAP/microtubule Affinity-Regulating Kinase 4 (MARK4))

Autre désignation: MARK4

Sujet: MARK4 contains an N terminal serine/threonine kinase domain, a central ubiquitin associated domain, and a C terminal KA1 associated kinase domain. RT PCR analysis detects upregulated expression of the gene for MARK4 in nearly all clinical hepatocellular carcinoma cells. Northern blot analysis reveals ubiquitous expression of a 3.6kb transcript, with highest expression in testis. Immunofluorescence microscopy demonstrates homogeneous cytoplasmic expression. Colony forming assays show that MARK4 antisense reduces the growth of SNU475 cells. It has been suggested that MARK4 provides a growth advantage to cells.Synonyms: MAP microtubule affinity-regulating kinase 4, MARKL1

ID gène: 57787

NCBI Accession: NP_113605

UniProt: Q96L34